PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 82 filers reported holding PLIANT THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,089,766 | -26.9% | 985,569 | -23.6% | 0.01% | -8.3% |
| Q2 2023 | $23,386,614 | -22.0% | 1,290,652 | +14.6% | 0.01% | -29.4% |
| Q1 2023 | $29,965,671 | +391.7% | 1,126,529 | +257.3% | 0.02% | +325.0% |
| Q4 2022 | $6,094,904 | -5.5% | 315,308 | +2.2% | 0.00% | 0.0% |
| Q3 2022 | $6,447,000 | +160.8% | 308,618 | 0.0% | 0.00% | +300.0% |
| Q2 2022 | $2,472,000 | +1515.7% | 308,618 | +1316.5% | 0.00% | – |
| Q1 2022 | $153,000 | -25.7% | 21,787 | +42.8% | 0.00% | – |
| Q4 2021 | $206,000 | -15.9% | 15,261 | +5.4% | 0.00% | – |
| Q3 2021 | $245,000 | -43.7% | 14,481 | -3.0% | 0.00% | – |
| Q2 2021 | $435,000 | -29.8% | 14,926 | -5.4% | 0.00% | – |
| Q1 2021 | $620,000 | +250.3% | 15,775 | +103.0% | 0.00% | – |
| Q4 2020 | $177,000 | +40.5% | 7,771 | +39.6% | 0.00% | – |
| Q3 2020 | $126,000 | – | 5,566 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 1,839,160 | $35,550,963 | 27.86% |
| TRV GP IV, LLC | 2,132,867 | $41,228,319 | 17.53% |
| CHI Advisors LLC | 3,169,892 | $61,274,012 | 16.32% |
| GREAT POINT PARTNERS LLC | 1,322,870 | $25,571,077 | 5.01% |
| VR Adviser, LLC | 1,080,000 | $20,876,400 | 3.52% |
| Redmile Group, LLC | 3,878,599 | $74,973,319 | 3.07% |
| Casdin Capital, LLC | 1,675,000 | $32,377,750 | 2.51% |
| Fernwood Investment Management, LLC | 304,573 | $5,887,396 | 2.44% |
| Cheyne Capital Management (UK) LLP | 66,144 | $1,278,564 | 2.23% |
| First Light Asset Management, LLC | 1,057,881 | $20,448,840 | 1.90% |